MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Overview Fund Activity
Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

27 hedge funds and large institutions have $4.15M invested in Medicenna Therapeutics Corp. Common Shares in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$25.7K
2
WVP
Worth Venture Partners
New Jersey
$524K
3
VF
Virtu Financial
New York
$10K
4
SPC
Sigma Planning Corp
Michigan
$147K
5
TSS
Two Sigma Securities
New York
$7.89K

Top Sellers

1
Millennium Management
Millennium Management
New York
$0
2
Renaissance Technologies
Renaissance Technologies
New York
$44K
3
LBA
Letko, Brosseau & Associates
Quebec, Canada
$57.8K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
$374K
5
Verition Fund Management
Verition Fund Management
Connecticut
$282K
Name Holding Trade Value Shares
Change 		Shares
Change %
National Bank of Canada
26
National Bank of Canada
Quebec, Canada
$272 +$272 +600 New
Millennium Management
27
Millennium Management
New York
– -$44K -68,215 Closed
BAM
28
Belpointe Asset Management
Nevada
– -$6.45K -10,249 Closed
ASN
29
Advisory Services Network
Georgia
– -$470 -747 Closed
1
2